Literature DB >> 33529135

Disruption of the Atrophy-based Functional Network in Multiple Sclerosis Is Associated with Clinical Disability: Validation of a Meta-Analytic Model in Resting-State Functional MRI.

Florence L Chiang1, Max Feng1, Rebecca S Romero1, Larry Price1, Crystal G Franklin1, Shengwen Deng1, Jodie P Gray1, Fang F Yu1, Bundhit Tantiwongkosi1, Susie Y Huang1, Peter T Fox1.   

Abstract

Background In multiple sclerosis (MS), gray matter (GM) atrophy exhibits a specific pattern, which correlates strongly with clinical disability. However, the mechanism of regional specificity in GM atrophy remains largely unknown. Recently, the network degeneration hypothesis (NDH) was quantitatively defined (using coordinate-based meta-analysis) as the atrophy-based functional network (AFN) model, which posits that localized GM atrophy in MS is mediated by functional networks. Purpose To test the NDH in MS in a data-driven manner using the AFN model to direct analyses in an independent test sample. Materials and Methods Model fit testing was conducted with structural equation modeling, which is based on the computation of semipartial correlations. Model verification was performed in coordinate-based data of healthy control participants from the BrainMap database (https://www.brainmap.org). Model validation was conducted in prospectively acquired resting-state functional MRI in participants with relapsing-remitting MS who were recruited between September 2018 and January 2019. Correlation analyses of model fit indices and volumetric measures with Expanded Disability Status Scale (EDSS) scores and disease duration were performed. Results Model verification of healthy control participants included 80 194 coordinates from 9035 experiments. Model verification in healthy control data resulted in excellent model fit (root mean square error of approximation, 0.037; 90% CI: 0.036, 0.039). Twenty participants (mean age, 36 years ± 9 [standard deviation]; 12 women) with relapsing-remitting MS were evaluated. Model validation in resting-state functional MRI in participants with MS resulted in deviation from optimal model fit (root mean square error of approximation, 0.071; 90% CI: 0.070, 0.072), which correlated with EDSS scores (r = 0.68; P = .002). Conclusion The atrophy-based functional network model predicts functional network disruption in multiple sclerosis (MS), thereby supporting the network degeneration hypothesis. On resting-state functional MRI scans, reduced functional network integrity in participants with MS had a strong positive correlation with clinical disability. © RSNA, 2021 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2021        PMID: 33529135      PMCID: PMC7997615          DOI: 10.1148/radiol.2021203414

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

Review 1.  The clinico-radiological paradox in multiple sclerosis revisited.

Authors:  Frederik Barkhof
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

2.  Unified structural equation modeling approach for the analysis of multisubject, multivariate functional MRI data.

Authors:  Jieun Kim; Wei Zhu; Linda Chang; Peter M Bentler; Thomas Ernst
Journal:  Hum Brain Mapp       Date:  2007-02       Impact factor: 5.038

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Neurodegenerative diseases target large-scale human brain networks.

Authors:  William W Seeley; Richard K Crawford; Juan Zhou; Bruce L Miller; Michael D Greicius
Journal:  Neuron       Date:  2009-04-16       Impact factor: 17.173

5.  Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis.

Authors:  F L Chiang; Q Wang; F F Yu; R S Romero; S Y Huang; P M Fox; B Tantiwongkosi; P T Fox
Journal:  Clin Radiol       Date:  2019-08-14       Impact factor: 2.350

6.  Correspondence of the brain's functional architecture during activation and rest.

Authors:  Stephen M Smith; Peter T Fox; Karla L Miller; David C Glahn; P Mickle Fox; Clare E Mackay; Nicola Filippini; Kate E Watkins; Roberto Toro; Angela R Laird; Christian F Beckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

7.  Evaluating and reducing the impact of white matter lesions on brain volume measurements.

Authors:  Marco Battaglini; Mark Jenkinson; Nicola De Stefano
Journal:  Hum Brain Mapp       Date:  2011-08-31       Impact factor: 5.038

8.  Progressive Bidirectional Age-Related Changes in Default Mode Network Effective Connectivity across Six Decades.

Authors:  Karl Li; Angela R Laird; Larry R Price; D Reese McKay; John Blangero; David C Glahn; Peter T Fox
Journal:  Front Aging Neurosci       Date:  2016-06-14       Impact factor: 5.750

Review 9.  Functional Connectivity in Multiple Sclerosis: Recent Findings and Future Directions.

Authors:  Marlene Tahedl; Seth M Levine; Mark W Greenlee; Robert Weissert; Jens V Schwarzbach
Journal:  Front Neurol       Date:  2018-10-11       Impact factor: 4.003

Review 10.  Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.

Authors:  Jeroen Van Schependom; Kaat Guldolf; Marie Béatrice D'hooghe; Guy Nagels; Miguel D'haeseleer
Journal:  Transl Neurodegener       Date:  2019-12-09       Impact factor: 8.014

View more
  1 in total

1.  Invariant structural and functional brain regions associated with tinnitus: A meta-analysis.

Authors:  John C Moring; Fatima T Husain; Jodie Gray; Crystal Franklin; Alan L Peterson; Patricia A Resick; Amy Garrett; Carlos Esquivel; Peter T Fox
Journal:  PLoS One       Date:  2022-10-18       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.